Levocarnitine Patent Expiration
Levocarnitine is Used for treating and preventing carnitine deficiency in end stage renal disease patients undergoing dialysis. It was first introduced by Leadiant Biosciences Inc
Levocarnitine Patents
Given below is the list of patents protecting Levocarnitine, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Carnitor | US6335369 | Treating chronic uremic patients undergoing periodical dialysis |
Jan 18, 2021
(Expired) | Leadiant Biosci Inc |
Carnitor | US6429230 | Treating chronic uremic patients undergoing periodical dialysis |
Jan 18, 2021
(Expired) | Leadiant Biosci Inc |
Carnitor | US6696493 | Treating chronic uremic patients undergoing periodic dialysis |
Jan 18, 2021
(Expired) | Leadiant Biosci Inc |
Levocarnitine's Family Patents
Explore Our Curated Drug Screens
Levocarnitine Generic API Manufacturers
Several generic applications have been filed for Levocarnitine. The first generic version for Levocarnitine was by Teva Pharmaceuticals Usa and was approved on Mar 29, 2001. And the latest generic version is by Novitium Pharma Llc and was approved on Dec 9, 2022.
Given below is the list of companies who have filed for Levocarnitine generic, along with the locations of their manufacturing plants worldwide.
1. AM REGENT
American Regent Inc has filed for 1 generic for Levocarnitine. Given below are the details of the strengths of this generic introduced by Am Regent.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/ML | injectable | Prescription | INJECTION | AP | Jun 22, 2001 |
2. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Levocarnitine. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/ML | injectable | Prescription | INJECTION | AP | Mar 29, 2001 |
1GM/10ML | solution | Discontinued | ORAL | N/A | Oct 25, 2007 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
3. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 2 different strengths of generic version for Levocarnitine. Out of these 1gm/10ml version comes by the name LEVOCARNITINE SF. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1GM/10ML | solution | Prescription | ORAL | AA | Aug 14, 2019 |
330MG | tablet | Prescription | ORAL | AB | Dec 9, 2022 |
Manufacturing Plant Locations New
Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
4. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Levocarnitine. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1GM/10ML | solution | Prescription | ORAL | AA | Aug 10, 2004 |
330MG | tablet | Prescription | ORAL | AB | Sep 20, 2004 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||
Mexico |
| |||||||||||||||||||
India |
|
5. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 1 generic for Levocarnitine. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1GM/10ML | solution | Prescription | ORAL | AA | Nov 10, 2021 |
6. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Levocarnitine. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/ML | injectable | Discontinued | INJECTION | N/A | Mar 29, 2001 |